Poxvirus tropism for primary human leukocytes and hematopoietic cells

Methods in Molecular Biology

Volumn 515, Issue , 2009, Pages 309-328

  Yu, Qigui ^a   Hu, Ningjie ^a   Ostrowski, Mario ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ALVAC; Dendritic cell; Enhanced green fluorescence protein; Monocyte; Myeloid cell; Peripheral blood mononuclear cell; Vaccinia; Virus

Indexed keywords

ANTIBODY; CYTOKINE; DNA;

ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; BLOOD CELL; CELL CULTURE; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; POXVIRUS; VIROLOGY;

ANTIBODIES; BLOOD CELLS; CELLS, CULTURED; CYTOKINES; DNA; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; ORGAN SPECIFICITY; POXVIRIDAE;

EID: 65649113639     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-559-6_22     Document Type: Article

References (33)

1. Moss, B. (1992) Vaccinia and other poxvirus expression vectors. Curr Opin Biotechnol 3, 518-22.
2. Moss, B., Fuerst, T.R., Flexner, C., Hugin, A. (1988) Roles of vaccinia virus in the development of new vaccines. Vaccine 6, 161-3. (Pubitemid 18089142)
3. Moss, B., Flexner, C. (1987) Vaccinia virus expression vectors. Annu Rev Immunol 5, 305-24.
4. Bostock, C.J. (1990) Viruses as vectors. Vet Microbiol 23, 55-71. (Pubitemid 20299891)
5. Fries, L.F., Tartaglia, J., Taylor, J., Kauffman, E.K., Meignier, B., Paoletti, E., Plotkin, S. (1996) Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. Vaccine 14, 428-34. (Pubitemid 26151876)
6. McFadden, G. (2005) Poxvirus tropism. Nat Rev Microbiol 3, 201-13. (Pubitemid 40298220)
7. Krugman, S., Katz, S.L. (1969) Smallpox vaccination . N Engl J Med 281, 1241-2.
8. Welter, J., Taylor, J., Tartaglia, J., Paoletti, E., Stephensen, C.B. (2000) Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J Virol 74, 6358-67. (Pubitemid 30429801)
9. Tartaglia, J., Jarrett, O., Neil, J.C., Desmettre, P., Paoletti, E. (1993) Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol 67, 2370-5. (Pubitemid 23088416)
10. Salmon-Ceron, D., Excler, J.L., Finkielsztejn, L., Autran, B., Gluckman, J.C., Sicard, D., Matthews, T.J., Meignier, B., Valentin, C., El Habib, R., Blondeau, C., Raux, M., Moog, C., Tartaglia, J., Chong, P., Klein, M., Milcamps, B., Heshmati, F., Plotkin, S. (1999) Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVACHIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le Sida. AIDS Res Hum Retroviruses 15, 633-45. (Pubitemid 29205667)
11. Karnasuta, C., Paris, R.M., Cox, J.H., Nitayaphan, S., Pitisuttithum, P., Thongcharoen , P., Brown, A.E., Gurunathan, S., Tartaglia , J., Heyward, W.L., McNeil, J.G., Birx, D.L., de Souza, M.S. (2005) Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVACHIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine 23, 2522-9. (Pubitemid 40332524)
12. Tartaglia, J., Perkus, M.E., Taylor, J., Norton, E.K., Audonnet, J.C., Cox, W.I., Davis, S.W., van der Hoeven, J., Meignier, B., Riviere, M., et al. (1992) NYVAC: a highly attenuated strain of vaccinia virus. Virology 188, 217-32.
13. Marovich, M.A., Mascola, J.R., Eller, M.A., Louder, M.K., Caudrelier, P.A., El-Habib, R., Ratto-Kim, S., Cox, J.H., Currier, J.R., Levine , B.L., June, C.H., Bernstein, W.B., Robb, M.L., Schuler-Thurner, B., Steinman, R.M., Birx, D.L., Schlesinger-Frankel, S. (2002) Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells. J Infect Dis 186, 1242-52. (Pubitemid 35193002)
14. Marovich, M.A. (2004) ALVAC-HIV vaccines: clinical trial experience focusing on progress in vaccine development. Expert Rev Vaccines 3, S99-S104. (Pubitemid 39120630)
15. Tartaglia, J., Cox, W.I., Taylor, J., Perkus, M., Riviere, M., Meignier, B., Paoletti, E. (1992) Highly attenuated poxvirus vectors. AIDS Res Hum Retroviruses 8, 1445-7.
16. Cox, W.I., Tartaglia, J., Paoletti, E. (1993) Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 195, 845-50.
17. Santra, S., Schmitz, J.E., Kuroda, M.J., Lifton, M.A., Nickerson, C.E., Lord, C.I., Pal, R., Franchini, G., Letvin, N.L. (2002) Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys. J Immunol 168, 1847-53. (Pubitemid 34135785)
18. Pal, R., Venzon, D., Letvin, N.L., Santra, S., Montefiori, D.C., Miller, N.R., Tryniszewska , E., Lewis, M.G., VanCott, T.C., Hirsch , V., Woodward, R., Gibson, A., Grace, M., Dobratz, E., Markham, P.D., Hel, Z., Nacsa, J., Klein, M., Tartaglia, J., Franchini, G. (2002) ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 76, 292-302. (Pubitemid 33139014)
19. Adler, S.P., Plotkin, S.A., Gonczol, E., Cadoz, M., Meric, C., Wang, J.B., Dellamonica, P., Best, A.M., Zahradnik, J., Pincus, S., Berencsi , K., Cox, W.I., Gyulai, Z. (1999) A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). J Infect Dis 180, 843-6. (Pubitemid 29411374)
20. Ghose, A., Iakhnina, E., Spaner, D., Tartaglia, J., Berinstein, N.L. (2000) Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector. Hum Gene Ther 11, 1289-301. (Pubitemid 30395985)
21. Konishi, E., Kurane, I., Mason, P.W., Shope, R.E., Kanesa-Thasan, N., Smucny, J.J., Hoke, C.H., Jr., Ennis, F.A. (1998) Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine 16, 842-9. (Pubitemid 28236654)
22. Ignatius, R., Marovich, M., Mehlhop, E., Villamide , L., Mahnke, K., Cox, W.I., Isdell, F., Frankel, S.S., Mascola, J.R., Steinman, R.M., Pope, M. (2000) Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion. J Virol 74, 11329-38. (Pubitemid 32224003)
23. Chahroudi, A., Chavan, R., Kozyr, N., Waller, E.K., Silvestri, G., Feinberg, M.B. (2005) Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J Virol 79, 10397-407. (Pubitemid 41098580)
24. Sanchez-Puig, J.M., Sanchez, L., Roy, G., Blasco, R. (2004) Susceptibility of different leukocyte cell types to Vaccinia virus infection . Virol J 1, 10.
25. Norbury, C.C., Malide, D., Gibbs, J.S., Bennink, J.R., Yewdell, J.W. (2002) Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 3, 265-71. (Pubitemid 34213428)
26. Ercolani, L., Florence, B., Denaro, M., Alexander , M. (1988) Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263, 15335-41.
27. Yu, Q., Kovacs, C., Yue, F.Y., Ostrowski, M.A. (2004) The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligandinduced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses. J Immunol 172, 6047-56. (Pubitemid 38621206)
28. Yu, Q., Gu, J.X., Kovacs, C., Freedman, J., Thomas, E.K., Ostrowski, M.A. (2003) Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. J Immunol 170, 1797-805. (Pubitemid 36197395)
29. Ostrowski, M.A., Justement, S.J., Ehler, L., Mizell, S.B., Lui, S., Mican, J., Walker, B.D., Thomas, E.K., Seder, R., Fauci, A.S. (2000) The role of CD4 + T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses. J Immunol 165, 6133-41.
30. Brinkman-Van der Linden, E.C., Angata, T., Reynolds, S.A., Powell, L.D., Hedrick, S.M., Varki, A. (2003) CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol 23, 4199-206. (Pubitemid 36666423)
31. Freeman, S.D., Kelm, S., Barber, E.K., Crocker, P.R. (1995) Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85, 2005-12.
32. Imamura, R., Miyamoto, T., Yoshimoto, G., Kamezaki, K., Ishikawa, F., Henzan, H., Kato, K., Takase, K., Numata, A., Nagafuji, K., Okamura, T., Sata, M., Harada, M., Inaba, S. (2005) Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor. J Immunol 175, 2647-54. (Pubitemid 41113880)
33. Yu, Q., Jones, B., Hu, N., Chang, H., Ahmad, S., Liu, J., Parrington, M., Yewdell, J., Ostrowski, M.A. (2006) Comparative analysis of tropism between Canarypox (ALVAC) and Vacciniaviruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage. Vaccine 24, 6376-91. (Pubitemid 44348912)